Role of Tofacitinib in Vitiligo Patients
Clinical trial NCT05293119 · UNKNOWN
Trial details
- NCT number
- NCT05293119
- Sponsor
- Pi Research Consultancy Center, Bangladesh
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-30
- Primary completion
- 2023-05-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.